Click a link below to view the mailing archive as if it had been sent to you.
| 2023-03-31 12:15 | | What M&A slowdown? Buyers circle GreenLight Biosciences, Egitis Therapeutics and more... |
| 2023-03-31 00:15 | | New lupus partnership with FDA aims to end drug trials’ history of failure and more... |
| 2023-03-30 12:15 | | Top biotech licensing deals of Q1 2023 and more... |
| 2023-03-30 00:15 | | Are ICU Medical & GE HealthCare Competing to Acquire 2 Units from Medtronic? and more... |
| 2023-03-29 12:15 | | J&J bows out of RSV vaccine race after scrapping trial and more... |
| 2023-03-29 00:15 | | Esperion, Daiichi Sankyo milestone payment feud heats up with new lawsuit and more... |
| 2023-03-28 12:15 | | Vertex ponies up $100M for CRISPR's gene editing tech to develop new diabetes modality and more... |
| 2023-03-28 00:15 | | Top 10 pharma R&D budgets in 2022 and more... |
| 2023-03-27 12:15 | | Novartis' Kisqali cuts recurrence risk in early-stage breast cancer and more... |
| 2023-03-27 00:15 | | Sanofi, Regeneron's Dupixent could hit $20B in peak sales with COPD expansion: analyst and more... |
| 2023-03-24 12:15 | | AbbVie clinches back-to-back clinical wins in ulcerative colitis, lupus and more... |
| 2023-03-24 00:15 | | Neurotechnology company Cognito Therapeutics scores $73M to study Alzheimer's device and more... |
| 2023-03-23 12:15 | | Moderna's gene therapy expansion picks up pace with $76M upfront Generation Bio collab and more... |
| 2023-03-23 00:15 | | In a surprise approval, FDA green-lights Incyte's PD-1 inhibitor to treat rare cancer type and more... |
| 2023-03-22 12:15 | | US again spurns march-in campaign to slash cost of Pfizer, Astellas' Xtandi and more... |
| 2023-03-22 00:15 | | Baxter attracts Thermo Fisher, Celltrion as potential buyers for biopharma contracting business and more... |
| 2023-03-21 12:15 | | FDA's Peter Marks backs accelerated approval for gene therapies and more... |
| 2023-03-21 00:15 | | Novartis: SMA Drug Zolgensma Long-term Data Shows Sustained Durability Up To 7.5 Years Post-dosing and more... |
| 2023-03-20 12:15 | | Neurofilament as a surrogate endpoint goes on trial in tofersen adcomm and more... |
| 2023-03-20 00:15 | | Takeda, chasing Bristol Myers, unveils awaited TYK2 drug data and more... |
| 2023-03-19 00:15 | | Most-clicked pharma news for week ending March 18 2023: Medtronic offers early retirement package, Novartis to sell ophthalmological assets, and Pfizer tops list of drugs with price increases |
| 2023-03-17 12:15 | | Alzheimer's Association campaigns for broader Leqembi coverage: report and more... |
| 2023-03-17 00:15 | | Three's company: Sanofi follows lead of Lilly and Novo, slashes insulin price by 78% and caps out-of-pocket costs and more... |
| 2023-03-16 12:15 | | Duchenne muscular dystrophy: major trials and events to watch in 2023 and more... |
| 2023-03-16 00:15 | | BioXcel takes surprising path with IPO of oncology spinout OnkosXcel and more... |
| 2023-03-15 12:15 | | Concentra's Buy Offer May Jeopardize Jounce's Merger with Redx and more... |
| 2023-03-15 00:15 | | In Pfizer-Seagen review, FTC has chance to set new pharma precedent and more... |
| 2023-03-14 12:15 | | After $3.4B deal and EU withdrawal, Novartis looks to sell Xiidra and more... |
| 2023-03-14 00:15 | | VA to cover Eisai's new Alzheimer's drug after declining to cover Aduhelm and more... |
| 2023-03-13 12:15 | | Pfizer to buy Seagen in $43B cancer drug deal and more... |
| 2023-03-13 01:15 | | Covering new weight loss drugs could strain Medicare, policy experts warn and more... |
| 2023-03-13 00:15 | | Covering new weight loss drugs could strain Medicare, policy experts warn and more... |
| 2023-03-10 12:15 | | Pfizer's Biohaven bet pays off again as migraine nasal spray wins approval and more... |
| 2023-03-10 00:15 | | FDA adcomm votes 11-2 to expand Roche's Polivy label in DLBCL and more... |
| 2023-03-09 12:15 | | Lilly’s Alzheimer’s struggles continue as preclinical asset fails phase III and more... |
| 2023-03-09 00:15 | | AstraZeneca draws back the curtains on its leadership team, launches new podcast and more... |
| 2023-03-08 12:15 | | FDA advisers question efficacy of Roche’s Polivy in first line LBCL and more... |
| 2023-03-08 00:15 | | Bristol Myers axes German launch of new cancer drug, citing pricing hurdles and more... |
| 2023-03-07 12:15 | | AbbVie CEO Gonzalez scored $26M in 2022 pay as cash cow Humira neared patent cliff and more... |
| 2023-03-07 00:15 | | FDA decision on preterm birth drug’s withdrawal nears, putting spotlight on patients, agency and more... |
| 2023-03-06 12:15 | | Future of generative AI in pharma and more... |
| 2023-03-06 00:15 | | Sangamo scraps public offering ‘after evaluating market conditions’ and more... |
| 2023-03-04 00:15 | | Roche, Exelixis Suffer Another Late-Stage Cancer Combo Failure and more... |
| 2023-03-03 12:15 | | Citing J&J's 'failure to comply' with court rules, judge nixes early bid to block Amgen's Stelara biosim and more... |
| 2023-03-03 00:15 | | AstraZeneca, Merck's Lynparza to face FDA panel in prostate cancer bid as PARP scrutiny escalates and more... |
| 2023-03-02 12:15 | | Novo Nordisk recruits new staff, lays off others as US R&D consolidated in Boston and more... |
| 2023-03-02 00:15 | | Roche sues Biogen over royalties related to multiple sclerosis drug Tysabri and more... |
| 2023-03-01 12:15 | | Lilly to cut insulin prices by 70%, cap prices at $35 per month for people with private insurance and more... |
| 2023-03-01 00:15 | | Pfizer's RSV vaccine wins support of FDA panel despite lingering safety and efficacy questions and more... |
